Yoshimi Nagai
- Ophthalmology top 1%
- Radiology, Nuclear Medicine and Imaging top 5%
- Epidemiology
- Molecular Biology
- Neurology
- Co-authors
- Kanji TakahashiMiyo MatsumuraMitsumasa WadaHiroshi MatsunagaM UyamaTakashi MatsubaraI FukushimaKenichiro Sho
- Topics
- Retinal Diseases and Treatments (9 papers)Retinal Imaging and Analysis (5 papers)Glaucoma and retinal disorders (5 papers)
- Partner nations
- JapanSwitzerlandUnited States
In The Last Decade
Yoshimi Nagai
9 papers receiving 470 citations
Peers
Comparison fields: 5 of 28
- Ophthalmology 474
- Radiology, Nuclear Medicine and Imaging 294
- Epidemiology 28
- Molecular Biology 18
- Neurology 11
Countries citing papers authored by Yoshimi Nagai
This map shows the geographic impact of Yoshimi Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Nagai more than expected).
Fields of papers citing papers by Yoshimi Nagai
This network shows the impact of papers produced by Yoshimi Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Nagai. The network helps show where Yoshimi Nagai may publish in the future.
Co-authorship network of co-authors of Yoshimi Nagai
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Nagai. A scholar is included among the top collaborators of Yoshimi Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Nagai. Yoshimi Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | Patient Preferences for Anti-VEGF Treatment Regimens for Wet Age-Related Macular Degeneration in Japan | 0 |
| 3 | Two-year outcome of aflibercept for treatment-naïve patient with neovascular age-related macular degeneration using modified treat-and-extend regimen | 3 |
| 4 | 27 | |
| 5 | 27 | |
| 6 | 54 | |
| 7 | [Evaluation of cases of polypoidal choroidal vasculopathy showing classic choroidal neovascularization in their natural course]. | 14 |
| 8 | 334 | |
| 9 | 2 | |
| 10 | 2 |
About Yoshimi Nagai
Yoshimi Nagai is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Complementary and alternative medicine, having authored 10 papers that have together received 485 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (9 papers), Retinal Imaging and Analysis (5 papers) and Glaucoma and retinal disorders (5 papers). The work is most often cited by research in Ophthalmology (474 citations), Radiology, Nuclear Medicine and Imaging (294 citations) and Epidemiology (28 citations). Yoshimi Nagai has collaborated with scholars based in Japan, Switzerland and United States. Frequent co-authors include Kanji Takahashi, Miyo Matsumura, Mitsumasa Wada, Hiroshi Matsunaga, M Uyama, Takashi Matsubara, I Fukushima, Kenichiro Sho, Yasushi Ikuno and Satoshi Matsuda. Their work appears in journals such as American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science and Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.